226 related articles for article (PubMed ID: 37947104)
21. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
23. A cross-sectional analysis of post-acute COVID-19 symptoms.
Perna S; Abdulsattar S; Alalwan TA; Zahid MN; Gasparri C; Peroni G; Faragli A; La Porta E; Ali Redha A; Janahi EM; Rondanelli M
Ann Ig; 2022; 34(5):478-489. PubMed ID: 35861720
[TBL] [Abstract][Full Text] [Related]
24. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
[TBL] [Abstract][Full Text] [Related]
26. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
[TBL] [Abstract][Full Text] [Related]
27. Protracted respiratory findings in children post-SARS-CoV-2 infection.
Leftin Dobkin SC; Collaco JM; McGrath-Morrow SA
Pediatr Pulmonol; 2021 Dec; 56(12):3682-3687. PubMed ID: 34534416
[TBL] [Abstract][Full Text] [Related]
28. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
29. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
Elife; 2023 Feb; 12():. PubMed ID: 36748905
[TBL] [Abstract][Full Text] [Related]
30. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
31. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
32. Risk factors associated with limited functional status among out-of-hospital patients 30 days and one year after a diagnosis of COVID-19: a cohort study.
Laskovski L; Felcar JM; Fillis MMA; Trelha CS
Sci Rep; 2023 Mar; 13(1):3584. PubMed ID: 36869060
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
35. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.
Malden DE; Tartof SY; Ackerson BK; Hong V; Skarbinski J; Yau V; Qian L; Fischer H; Shaw SF; Caparosa S; Xie F
JMIR Public Health Surveill; 2022 Dec; 8(12):e41529. PubMed ID: 36446133
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and impact of Long Covid: Findings from an online survey.
Ziauddeen N; Gurdasani D; O'Hara ME; Hastie C; Roderick P; Yao G; Alwan NA
PLoS One; 2022; 17(3):e0264331. PubMed ID: 35259179
[TBL] [Abstract][Full Text] [Related]
37. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
[TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
39. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Thomas S; Patel D; Bittel B; Wolski K; Wang Q; Kumar A; Il'Giovine ZJ; Mehra R; McWilliams C; Nissen SE; Desai MY
JAMA Netw Open; 2021 Feb; 4(2):e210369. PubMed ID: 33576820
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Headache and Cognitive Complaints Among Health Care Workers Who Acquired SARS-CoV-2.
Marques AJ; Costa A; Almendra R; Maia L; Magalhães R; Cavaco S; Oliveira V; Correia M; Mendes M; Veiga A
Perm J; 2023 Sep; 27(3):14-21. PubMed ID: 37246366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
